Jane E. Cavanaugh - Publications

Pharmacology Duquesne University, Pittsburgh, PA, United States 
Aging, Pharmacology, Neuroscience Biology

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Potdar S, Parmar MS, Ray SD, Cavanaugh JE. Protective effects of the resveratrol analog piceid in dopaminergic SH-SY5Y cells. Archives of Toxicology. PMID 28980048 DOI: 10.1007/s00204-017-2073-z  0.48
2015 Parmar MS, Jaumotte JD, Zigmond MJ, Cavanaugh JE. ERK1, 2, and 5 expression and activation in dopaminergic brain regions during postnatal development. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 46: 44-50. PMID 26363522 DOI: 10.1016/j.ijdevneu.2015.06.009  0.48
2014 Rose KM, Parmar MS, Cavanaugh JE. Dietary supplementation with resveratrol protects against striatal dopaminergic deficits produced by in utero LPS exposure. Brain Research. 1573: 37-43. PMID 24863468 DOI: 10.1016/j.brainres.2014.05.028  0.48
2014 Allen EN, Cavanaugh JE. Loss of motor coordination in an aging mouse model. Behavioural Brain Research. 267: 119-25. PMID 24675158 DOI: 10.1016/j.bbr.2014.03.032  0.48
2014 Parmar MS, Jaumotte JD, Wyrostek SL, Zigmond MJ, Cavanaugh JE. Role of ERK1, 2, and 5 in dopamine neuron survival during aging. Neurobiology of Aging. 35: 669-79. PMID 24411019 DOI: 10.1016/j.neurobiolaging.2013.09.031  0.48
2011 Allen E, Carlson KM, Zigmond MJ, Cavanaugh JE. L-DOPA reverses motor deficits associated with normal aging in mice. Neuroscience Letters. 489: 1-4. PMID 21111775 DOI: 10.1016/j.neulet.2010.11.054  0.48
2008 Lin E, Cavanaugh JE, Leak RK, Perez RG, Zigmond MJ. Rapid activation of ERK by 6-hydroxydopamine promotes survival of dopaminergic cells. Journal of Neuroscience Research. 86: 108-17. PMID 17847117 DOI: 10.1002/jnr.21478  0.48
2006 Cavanaugh JE, Jaumotte JD, Lakoski JM, Zigmond MJ. Neuroprotective role of ERK1/2 and ERK5 in a dopaminergic cell line under basal conditions and in response to oxidative stress. Journal of Neuroscience Research. 84: 1367-75. PMID 16941494 DOI: 10.1002/jnr.21024  0.48
2004 Cavanaugh JE. Role of extracellular signal regulated kinase 5 in neuronal survival. European Journal of Biochemistry / Febs. 271: 2056-9. PMID 15153094 DOI: 10.1111/j.1432-1033.2004.04131.x  0.48
2003 Liu L, Cavanaugh JE, Wang Y, Sakagami H, Mao Z, Xia Z. ERK5 activation of MEF2-mediated gene expression plays a critical role in BDNF-promoted survival of developing but not mature cortical neurons. Proceedings of the National Academy of Sciences of the United States of America. 100: 8532-7. PMID 12826611 DOI: 10.1073/pnas.1332804100  0.48
2002 Karpa KD, Cavanaugh JE, Lakoski JM. Duloxetine pharmacology: profile of a dual monoamine modulator. Cns Drug Reviews. 8: 361-76. PMID 12481192  0.48
Show low-probability matches.